ロード中...
Rapid clearance of erythrodermic psoriasis with apremilast
BACKGROUND: Apremilast is a new immunomodulatory drug, a small molecule inhibitor of PDE4, which down-regulates the expression of multiple pro-inflammatory cytokines, such as tumor necrosis factor alpha, interleukin 17, interleukin 23. MAIN OBSERVATIONS: We describe a case of a 54-year-old man with...
保存先:
| 出版年: | J Dermatol Case Rep |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Specjalisci Dermatolodzy
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5776028/ https://ncbi.nlm.nih.gov/pubmed/29367871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3315/jdcr.2017.1246 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|